Stage 3 prostate cancer is locally advanced, with tumors extending beyond the prostate but not metastasizing distantly. Diagnosis involves the TNM system, Gleason score, PSA tests, and imaging to ...

Stage 2 prostate adenocarcinoma is localized, with a nearly 100% five-year relative survival rate. Diagnosis uses the TNM system, PSA levels, and Gleason score to determine cancer stage and risk.

Prostate adenocarcinoma represents the most common form of prostate cancer, affecting nearly all cases diagnosed in men. This specific type develops in the gland cells that produce prostate fluid, ...

Alpha Tau Medical Ltd ($DRTS) announced an update on their ongoing clinical study. Alpha Tau Medical Ltd (DRTS) has recently completed a clinical ...

Grade group 1 and ASAP on prostate biopsy predict future prostate cancer risk and should not be ignored. Prostate biopsy findings of Gleason grade group (GG) 1 or atypical small acinar proliferation ...

People assigned female at birth can't get prostate cancer because they don't have a prostate gland. However, women can get a rare type of cancer that develops in the Skene's glands, a pair of organs ...